Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

1.

MicroRNA-34a perturbs B lymphocyte development by repressing the forkhead box transcription factor Foxp1.

Rao DS, O'Connell RM, Chaudhuri AA, Garcia-Flores Y, Geiger TL, Baltimore D.

Immunity. 2010 Jul 23;33(1):48-59. doi: 10.1016/j.immuni.2010.06.013. Epub 2010 Jul 1.

PMID:
20598588
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

The type 1 diabetes resistance locus B10 Idd9.3 mediates impaired B-cell lymphopoiesis and implicates microRNA-34a in diabetes protection.

Berry GJ, Budgeon LR, Cooper TK, Christensen ND, Waldner H.

Eur J Immunol. 2014 Jun;44(6):1716-27. doi: 10.1002/eji.201344116. Epub 2014 Apr 29.

PMID:
24752729
[PubMed - indexed for MEDLINE]
3.

Myc-mediated repression of microRNA-34a promotes high-grade transformation of B-cell lymphoma by dysregulation of FoxP1.

Craig VJ, Cogliatti SB, Imig J, Renner C, Neuenschwander S, Rehrauer H, Schlapbach R, Dirnhofer S, Tzankov A, Müller A.

Blood. 2011 Jun 9;117(23):6227-36. doi: 10.1182/blood-2010-10-312231. Epub 2011 Apr 1.

PMID:
21460242
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

C/EBPa-mediated activation of microRNAs 34a and 223 inhibits Lef1 expression to achieve efficient reprogramming into macrophages.

Rodriguez-Ubreva J, Ciudad L, van Oevelen C, Parra M, Graf T, Ballestar E.

Mol Cell Biol. 2014 Mar;34(6):1145-57. doi: 10.1128/MCB.01487-13. Epub 2014 Jan 13.

PMID:
24421386
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Connective tissue growth factor modulates oral squamous cell carcinoma invasion by activating a miR-504/FOXP1 signalling.

Yang MH, Lin BR, Chang CH, Chen ST, Lin SK, Kuo MY, Jeng YM, Kuo ML, Chang CC.

Oncogene. 2012 May 10;31(19):2401-11. doi: 10.1038/onc.2011.423. Epub 2011 Sep 19. Erratum in: Oncogene. 2013 Jan 31;32(5):670.

PMID:
21927029
[PubMed - indexed for MEDLINE]
6.

Prognostic significance of miR-34a and its target proteins of FOXP1, p53, and BCL2 in gastric MALT lymphoma and DLBCL.

He M, Gao L, Zhang S, Tao L, Wang J, Yang J, Zhu M.

Gastric Cancer. 2014 Jul;17(3):431-41. doi: 10.1007/s10120-013-0313-3. Epub 2013 Nov 14.

PMID:
24232982
[PubMed - in process]
7.

miR-34 and SNAIL form a double-negative feedback loop to regulate epithelial-mesenchymal transitions.

Siemens H, Jackstadt R, Hünten S, Kaller M, Menssen A, Götz U, Hermeking H.

Cell Cycle. 2011 Dec 15;10(24):4256-71. doi: 10.4161/cc.10.24.18552. Epub 2011 Dec 15.

PMID:
22134354
[PubMed - indexed for MEDLINE]
8.

Regulation of the MIR155 host gene in physiological and pathological processes.

Elton TS, Selemon H, Elton SM, Parinandi NL.

Gene. 2013 Dec 10;532(1):1-12. doi: 10.1016/j.gene.2012.12.009. Epub 2012 Dec 14. Review.

PMID:
23246696
[PubMed - indexed for MEDLINE]
9.

MicroRNA-34a inhibits migration and invasion of colon cancer cells via targeting to Fra-1.

Wu J, Wu G, Lv L, Ren YF, Zhang XJ, Xue YF, Li G, Lu X, Sun Z, Tang KF.

Carcinogenesis. 2012 Mar;33(3):519-28. doi: 10.1093/carcin/bgr304. Epub 2011 Dec 22.

PMID:
22198213
[PubMed - indexed for MEDLINE]
Free Article
10.

Downregulation of FOXP1 is required during germinal center B-cell function.

Sagardoy A, Martinez-Ferrandis JI, Roa S, Bunting KL, Aznar MA, Elemento O, Shaknovich R, Fontán L, Fresquet V, Perez-Roger I, Robles EF, De Smedt L, Sagaert X, Melnick A, Martinez-Climent JA.

Blood. 2013 May 23;121(21):4311-20. doi: 10.1182/blood-2012-10-462846. Epub 2013 Apr 11.

PMID:
23580662
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

FOXP1 acts through a negative feedback loop to suppress FOXO-induced apoptosis.

van Boxtel R, Gomez-Puerto C, Mokry M, Eijkelenboom A, van der Vos KE, Nieuwenhuis EE, Burgering BM, Lam EW, Coffer PJ.

Cell Death Differ. 2013 Sep;20(9):1219-29. doi: 10.1038/cdd.2013.81. Epub 2013 Jul 5.

PMID:
23832113
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

MicroRNA-34a induces endothelial progenitor cell senescence and impedes its angiogenesis via suppressing silent information regulator 1.

Zhao T, Li J, Chen AF.

Am J Physiol Endocrinol Metab. 2010 Jul;299(1):E110-6. doi: 10.1152/ajpendo.00192.2010. Epub 2010 Apr 27.

PMID:
20424141
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

MicroRNA-34a is induced via p53 during cisplatin nephrotoxicity and contributes to cell survival.

Bhatt K, Zhou L, Mi QS, Huang S, She JX, Dong Z.

Mol Med. 2010 Sep-Oct;16(9-10):409-16. doi: 10.2119/molmed.2010.00002. Epub 2010 Apr 9.

PMID:
20386864
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

p53 Ser15 phosphorylation and histone modifications contribute to IR-induced miR-34a transcription in mammary epithelial cells.

Wang B, Li D, Kovalchuk O.

Cell Cycle. 2013 Jul 1;12(13):2073-83. doi: 10.4161/cc.25135. Epub 2013 Jun 6.

PMID:
23759592
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Myc overexpression brings out unexpected antiapoptotic effects of miR-34a.

Sotillo E, Laver T, Mellert H, Schelter JM, Cleary MA, McMahon S, Thomas-Tikhonenko A.

Oncogene. 2011 Jun 2;30(22):2587-94. doi: 10.1038/onc.2010.634. Epub 2011 Feb 7.

PMID:
21297663
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

The p53 transcription factor modulates microglia behavior through microRNA-dependent regulation of c-Maf.

Su W, Hopkins S, Nesser NK, Sopher B, Silvestroni A, Ammanuel S, Jayadev S, Möller T, Weinstein J, Garden GA.

J Immunol. 2014 Jan 1;192(1):358-66. doi: 10.4049/jimmunol.1301397. Epub 2013 Dec 6.

PMID:
24319262
[PubMed - indexed for MEDLINE]
17.

Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells.

Fujita Y, Kojima K, Hamada N, Ohhashi R, Akao Y, Nozawa Y, Deguchi T, Ito M.

Biochem Biophys Res Commun. 2008 Dec 5;377(1):114-9. doi: 10.1016/j.bbrc.2008.09.086. Epub 2008 Oct 1.

PMID:
18834855
[PubMed - indexed for MEDLINE]
18.

microRNA-34a expression correlates with MDM2 SNP309 polymorphism and treatment-free survival in chronic lymphocytic leukemia.

Asslaber D, Piñón JD, Seyfried I, Desch P, Stöcher M, Tinhofer I, Egle A, Merkel O, Greil R.

Blood. 2010 May 27;115(21):4191-7. doi: 10.1182/blood-2009-07-234823. Epub 2010 Jan 20.

PMID:
20089965
[PubMed - indexed for MEDLINE]
Free Article
19.

The over-expression of miR-34a fails to block DoHH2 lymphoma cell proliferation by reducing p53 via c-MYC down-regulation.

Rizzo M, Mariani L, Cavallini S, Simili M, Rainaldi G.

Nucleic Acid Ther. 2012 Aug;22(4):283-8. doi: 10.1089/nat.2012.0343. Epub 2012 Jul 25.

PMID:
22830357
[PubMed - indexed for MEDLINE]
20.

MiR-34a inhibits lipopolysaccharide-induced inflammatory response through targeting Notch1 in murine macrophages.

Jiang P, Liu R, Zheng Y, Liu X, Chang L, Xiong S, Chu Y.

Exp Cell Res. 2012 Jun 10;318(10):1175-84. doi: 10.1016/j.yexcr.2012.03.018. Epub 2012 Mar 27.

PMID:
22483937
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk